Comment
The ideal method of ®xing catheters would encompass optimal security of the catheter, ease of inspection and maintenance of sterility at the site of insertion. Not only must an application function in dry conditions, but it must retain this ef®cacy after exposure to blood, perspiration and epidural solution. Placement of a Tegaderm over a loop of catheter (group T) is the routine method of catheter ®xation in our hospital. Fixation of a particulate ®lter (group F) was undertaken to examine whether this stabilized the catheter further. The Niko Epi-Fix (used in group N) is a ®xation device that has been introduced recently, speci®cally for securing an epidural catheter. The cost of this device is comparable to that of the Tegaderm dressing (£1.50 and £1.24 respectively; September 2000).
Outward movement of the epidural catheter was greatest when a Niko Epi-Fix dressing was used to secure the catheter, and was associated with signi®cantly more failures in analgesia. However, when attempting to minimize movement of the catheter irrespective of direction, only the Tegaderm dressing with additional ®lter ®xation confers a signi®cant advantage over the Niko Epi-Fix.
We identi®ed no correlation between epidural catheter movement and the duration of catheter presence, a ®nding in concordance with earlier work. 6 Additionally, we showed that neither the use of a small skin incision at the site of catheter insertion, nor the selected inter-vertebral level affected movement of the epidural catheter. A previous study 1 demonstrated that body mass index is related to amount of catheter movement. Our data con®rmed this association in group F but was unable to show this in the remainder of the patients, perhaps because inadequate numbers of people were studied.
clinically greater in the fentanyl group (P=0.01). Maternal hypotension, pruritis, proprioceptive loss, nausea and fetal bradycardia were rare and not severe, and their incidences did not differ between groups. No respiratory depression was observed after CSE. This use of diamorphine was not associated with increased side-effects compared with fentanyl/bupivacaine, and it has a longer duration of action. The combined spinal±epidural (CSE) technique for initiation of mobile analgesia in labour is now used widely in obstetric anaesthetic practice. It is said to offer the advantages of rapid onset of analgesia via the spinal route with the¯exibility of epidural top-ups later in labour or for obstetric procedures. We decided to investigate the possibility of replacing the intrathecal fentanyl usually used with diamorphine to attempt to prolong the analgesic effect without increasing the incidence of side-effects.
Methods and results
Local ethics committee approval was granted for this study. Over a 3 month period, all women attending our delivery suite in labour and requesting epidural analgesia were informed about the project. Sixty-two women were recruited. All had singleton pregnancies, were at more than 36 weeks of gestation and had a cephalic presentation. Those who had received opioids within 4 h were excluded.
After i.v. access had been secured, the epidural was sited at L2/3 or L3/4 with the patient sitting. Patients were allocated to one of two groups: group F received isobaric bupivacaine 2.5 mg plus fentanyl 25 mg, total volume 1.5 ml (n=32); group D received isobaric bupivacaine 2.5 mg plus diamorphine 250 mg, total volume 1.5 ml (n=30). The appropriate mixture was injected intrathecally through a 26 G Whitacre needle using a needle-through-needle technique. Cerebrospinal¯uid aspirates were tested before and after injection, and the time of injection was noted. The attending midwife was unaware of the group allocation. Pulse, blood pressure and cardiotocograph recordings were carried out as normal.
The times to the ®rst comfortable contraction (freedom from pain regardless of block height; t 1 ) and to ®rst top-up request (t 2 ) were recorded by the midwife. Patients were told to inform their midwife as soon as the pain of contractions recurred. Maternal hypotension (systolic blood pressure less than 90 mm Hg or a reduction of more than 20 mm Hg from baseline or symptomatic), nausea, vomiting, pruritis and fetal bradycardia (less than 100 beats min ±1 ) were recorded and treated if necessary. Proprioception and lower limb power were assessed 30 min after injection using hallux positioning and modi®ed Bromage scoring respectively. All patients were observed every 4 h for 24 h after treatment for evidence of respiratory depression. A respiratory rate greater than 9 b.p.m. was taken as adequate. All subsequent top-ups were opioid-free (0.2% ropivacaine 10±15 ml) to avoid worsening any potential respiratory depression resulting from the intrathecal opioid.
The two groups were similar in terms of age, parity and induction and augmentation rates. Cervical dilation was similar in the two groups (group D, mean 4.0 cm, ®ve patients >5 cm dilated; group F, mean 4.1 cm, seven patients >5 cm dilated). Two women were withdrawn from group D (one analgesic failure, one delivery) and one from group F (analgesic failure). Results from the remaining 59 patients were analysed using the t test, the c 2 test, the Mann±Whitney U-test and the Kruskal±Wallis test as appropriate. The results are summarized in Table 1 . A P value less than 0.05 was taken as signi®cant.
Our results show a clear increase in time to ®rst top-up request in group D compared with group F, with no signi®cant difference in onset times. All episodes of fetal bradycardia were transient and required no treatment. All three episodes of maternal hypotension resolved with 500 ml of crystalloid and, in one case, a 6 mg bolus of ephedrine. Pruritis was more common with fentanyl, but only one patient of the ®ve with pruritis required treatment with i.v. naloxone 200 mg. There were no instances of nausea or vomiting requiring treatment. Proprioceptive de®cits were uncommon in both groups but modi®ed Bromage scores revealed signi®cantly greater motor loss in the fentanyl 
Comments
This study shows that the use of 250 mg diamorphine, when compared with fentanyl 25 mg, given intrathecally with bupivacaine 2.5 mg does not produce a signi®cant increase in side-effects and carries bene®t in terms of prolongation of analgesic action. The onset time is similar in the two groups, the difference being 1.5 min or at most one contraction. A difference was noted in power assessment statistically, but clinically all patients were able to mobilize safely. The CSE is a technique commonly used to initiate labour analgesia. There is ongoing debate in the literature about whether the bene®ts offered by this approach to the labouring woman above those seen with a low-dose epidural outweigh the perceived small increase in risk associated with deliberate dural puncture.
1±6 This argument has yet to be resolved, but it is clear that an increase in the duration of action of the initial dose results in less breakthrough pain during labour, a factor registered as important in studies of maternal satisfaction. 7 The ultimate aim may be a singleintervention method of complete analgesia throughout childbirth, and our study indicates a possible step in the right direction. Decreasing the need for top-ups and associated medical/midwifery interventions may also result in a decrease in staff workload.
The dose of diamorphine used in this study was deliberately low because of worries regarding side-effects, principally pruritis and respiratory depression. Diamorphine was chosen in place of morphine because of its much higher oil/water partition coef®cient (morphine 1.4, diamorphine 280, fentanyl 816). 8 Doses of 500 mg diamorphine alone have been reported for intrathecal labour analgesia without respiratory depression occurring. 9 Morphine has been reported to cause delayed respiratory depression and even apnoea with doses as low as 1 mg intrathecally, 8 10 and thus, as a dose of 1±2 mg is reported to be necessary for signi®cant bene®t, 10 11 it cannot be used reliably and safely in labour. Although we have found no evidence of respiratory depression with diamorphine 250 mg intrathecally, we have not proved conclusively that it will never occur. Care must always be taken in the post-delivery monitoring of these patients.
Recent studies have shown effective analgesia with doses of intrathecal opioid lower than those commonly used. 12 It may be that the prolongation of action seen with diamorphine requires less than this 250 mg dose. It may also be that this extension of time to ®rst top-up is increased with a higher intrathecal dose. It seems likely that we have detected an enhanced bupivacaine-sparing effect and that extension of this effect is dependent on local anaesthetic concentration at the effector site combined with improved or prolonged spinal opioid receptor stimulation. To what degree further extension of time to ®rst top-up is possible remains to be elucidated, as does the minimum dose of diamorphine required to produce this effect.
